S. Nagi Reddy 's Insider Trades & SAST Disclosures
S. Nagi Reddy 's most recent trade in Concord Drugs Ltd. was a Disposal of 171,133 Warrants done at an average price of Rs. 24.8 . Disclosure was reported to the exchange on Oct. 30, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
S. Nagi Reddy 's has made SAST transactions in Concord Drugs Ltd. recently where a Acquisition of 342,266 shares done . Disclosure was reported to the exchange on Oct. 30, 2023.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | S Nagi Reddy & PACs | Promoter | Acquisition | 31 Oct 2023 | 342,266 | 5,540,649 (55.40%) | 3.52% | - | 27 Oct 2023 27 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Disposal | 30 Oct 2023 | 171,133 | 0 (0%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Acquisition | 30 Oct 2023 | 171,133 | 2,912,524 (29.12%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S Nagi Reddy & PACs | Promoter | Acquisition | 17 Oct 2023 | 342,264 | 5,198,383 (53.83%) | 3.54% | - | 12 Oct 2023 12 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Disposal | 14 Oct 2023 | 171,132 | 171,133 (0%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Acquisition | 14 Oct 2023 | 171,132 | 2,741,391 (28.39%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Disposal | 29 Mar 2023 | 285,860 | 342,265 (0%) | 3.17% | 24.7 | 7,075,000 | 27 Mar 2023 27 Mar 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 29 Mar 2023 | 285,860 | 2,570,259 (28.46%) | 3.17% | 24.7 | 7,075,000 | 27 Mar 2023 27 Mar 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S. Nagi Reddy & PAC | Promoter | Acquisition | 31 Mar 2023 | 285,860 | 2,570,259 (28.46%) | 3.16% | - | 27 Mar 2023 27 Mar 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 09 Nov 2022 | 628,125 | 628,125 (0%) | 7.18% | 8.3 | 5,182,032 | 07 Nov 2022 07 Nov 2022 |
Insider Trading | Warrants | Preferential Offer |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 15 Nov 2021 | 397,500 | 2,284,399 (26.13%) | 4.55% | 0 | 0 | 15 Nov 2021 15 Nov 2021 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Concord Drugs | S Nagi Reddy | Other | Acquisition | 15 Nov 2021 | 397,500 | - | 4.55% | - | 15 Nov 2021 15 Nov 2021 |
SAST (10(6)) | - | - | |
| Concord Drugs | S Nagi Reddy | Promoter | Acquisition | 16 Nov 2021 | 397,500 | 2,284,399 (26.13%) | 4.55% | - | 15 Nov 2021 15 Nov 2021 |
SAST (29(2)) | - | Inter-se Transfer | |
| Concord Drugs | S Nagi Reddy | Promoter | Acquisition | 05 Nov 2021 | 397,500 | - | 4.55% | - | 15 Nov 2021 15 Nov 2021 |
SAST (10(1)(a)) | - | None | |
| Concord Drugs | S Nagi Reddy | Promoter | Acquisition | 12 Oct 2021 | 397,500 | - | 4.55% | - | 22 Oct 2021 22 Oct 2021 |
SAST (10(1)(a)) | - | None | |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 24 Sep 2021 | 44,359 | 1,886,899 (21.58%) | 0.51% | 28.0 | 1,241,943 | 24 Aug 2021 24 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 25 Sep 2021 | 44,359 | 1,886,899 (21.58%) | 0.51% | - | 24 Aug 2021 24 Sep 2021 |
SAST (29(2)) | - | Market | |
| Concord Drugs | Nagi Reddy Seelam | Promoter & Director | Acquisition | 04 Mar 2021 | 84,145 | 1,842,540 (21.07%) | 0.96% | 25.0 | 2,103,295 | 02 Mar 2021 03 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 06 Mar 2021 | 84,145 | 1,842,540 (21.07%) | 0.96% | - | 02 Mar 2021 03 Mar 2021 |
SAST (29(2)) | - | Market | |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 02 Mar 2021 | 55,395 | 1,758,395 (20.11%) | 0.63% | 25.0 | 1,384,729 | 25 Feb 2021 01 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 03 Mar 2021 | 55,395 | 1,758,395 (20.11%) | 0.63% | - | 25 Feb 2021 01 Mar 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.